Ploder Rodolfo O - 10 Feb 2023 Form 4 Insider Report for EQUIFAX INC (EFX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 Feb 2023, 15:13:59 UTC
Prior SEC filing
24 Feb 2022
Next SEC filing
23 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Lisa Stockard as Attorney-in-Fact

Key filing fact

Ploder Rodolfo O filed Form 4 for EQUIFAX INC (EFX) on 14 Feb 2023.

Key facts

  • This page summarizes Ploder Rodolfo O's Form 4 filing for EQUIFAX INC (EFX).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 14 Feb 2023, 15:13.

Change

  • Previous filing in this sequence was filed on 24 Feb 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EFX transaction

Common Stock

Award

Transaction value
$0
Shares
+4,245
Change %
+5.3%
Price
$0.000000
Shares after
84,456
Date
10 Feb 2023
Ownership
Direct
Footnotes
F1, F2
EFX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
445
Date
10 Feb 2023
Ownership
By 401(k)

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EFX transaction Derivative

Stock Option/Right to Buy

Award

Transaction value
$0
Shares
+13,530
Change %
Price
$0.000000
Shares after
13,530
Date
10 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
13,530
Exercise price
$206.16
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2026.

Footnote F2

Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

Footnote F3

Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .